2025 Europe Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report
Description
The 2025 Europe Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automatic Nucleic Acid Extraction Instrument market in Europe are QIAGEN NV, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and PerkinElmer Inc. These companies are major global players known for their extensive product portfolios and strong market presence across Western and Eastern Europe. QIAGEN NV, headquartered in Germany, is a leading provider of sample and assay technologies serving molecular diagnostics, applied testing, and academic research. F. Hoffmann-La Roche AG, a Swiss multinational, offers high-quality automated extraction instruments integrated with their diagnostic solutions. Thermo Fisher Scientific Inc., a U.S.-based leader with a robust presence in Europe, delivers advanced automated liquid handling and nucleic acid extraction platforms. PerkinElmer Inc. also contributes with innovative extraction instruments designed for clinical and research laboratories in Europe.
These companies are driving market growth through investments in R&D, expansion of automation technologies, and responding to increasing demands for rapid, accurate molecular diagnostic testing fueled by rising infectious diseases and personalized medicine adoption. The European region benefits from their localized operations, compliance with stringent regulatory standards, and collaboration with research institutions and healthcare providers. The automated nucleic acid extraction market in Europe is part of a global segment predicted to grow at a double-digit CAGR, reflecting ongoing technological evolution and increasing healthcare infrastructure investments led in part by these industry leaders.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automatic Nucleic Acid Extraction Instrument market in Europe are QIAGEN NV, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and PerkinElmer Inc. These companies are major global players known for their extensive product portfolios and strong market presence across Western and Eastern Europe. QIAGEN NV, headquartered in Germany, is a leading provider of sample and assay technologies serving molecular diagnostics, applied testing, and academic research. F. Hoffmann-La Roche AG, a Swiss multinational, offers high-quality automated extraction instruments integrated with their diagnostic solutions. Thermo Fisher Scientific Inc., a U.S.-based leader with a robust presence in Europe, delivers advanced automated liquid handling and nucleic acid extraction platforms. PerkinElmer Inc. also contributes with innovative extraction instruments designed for clinical and research laboratories in Europe.
These companies are driving market growth through investments in R&D, expansion of automation technologies, and responding to increasing demands for rapid, accurate molecular diagnostic testing fueled by rising infectious diseases and personalized medicine adoption. The European region benefits from their localized operations, compliance with stringent regulatory standards, and collaboration with research institutions and healthcare providers. The automated nucleic acid extraction market in Europe is part of a global segment predicted to grow at a double-digit CAGR, reflecting ongoing technological evolution and increasing healthcare infrastructure investments led in part by these industry leaders.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
